skip to content
Ciprofloxacin or doxycycline for the treatment of anthrax : a review of the clinical and cost-effectiveness Preview this item
ClosePreview this item
Checking...

Ciprofloxacin or doxycycline for the treatment of anthrax : a review of the clinical and cost-effectiveness

Author: Canadian Agency for Drugs and Technologies in Health.
Publisher: [Ottawa, Ont.] : Canadian Agency for Drugs and Technologies in Health, 2012
Series: Rapid response report.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
The potential use of anthrax as a biological terrorist attack has prompted health authorities to investigate different treatment protocols and discuss which antibiotic agent should be used in the event of an attack. Ciprofloxacin, and doxycycline were the primary agents used after the 2001 attack in the US, and amoxicillin was reserved for pregnant or breast feeding women, children, and those with adverse effects  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Canadian Agency for Drugs and Technologies in Health.
OCLC Number: 830009056
Notes: "27 November 2012."
Description: 1 online resource (13 pages) : tables, digital file.
Series Title: Rapid response report.
Responsibility: [prepared by Canadian Agency for Drugs and Technologies in Health].
More information:

Abstract:

The potential use of anthrax as a biological terrorist attack has prompted health authorities to investigate different treatment protocols and discuss which antibiotic agent should be used in the event of an attack. Ciprofloxacin, and doxycycline were the primary agents used after the 2001 attack in the US, and amoxicillin was reserved for pregnant or breast feeding women, children, and those with adverse effects associated with ciprofloxacin or doxycycline. Re-evaluation of these agents is required over time considering changes in resistance patterns, costs, or other factors. This report will review the clinical and cost-effectiveness literature of ciprofloxacin and doxycycline for anthrax.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.